查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1676836

受託研究机构服务市场按类型、测试类型、治疗领域和最终用户划分 - 2025 年至 2030 年全球预测

Contract Research Organizations Services Market by Type, Testing Type, Therapeutic Area, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

受託研究机构服务市场预计将从 2024 年的 774.2 亿美元成长到 2025 年的 857.2 亿美元，复合年增长率为 10.92%，到 2030 年达到 1,442 亿美元。

主要市场统计数据
基准年 2024 年 774.2亿美元
预计 2025 年 857.2亿美元
预测年份 2030 1,442亿美元
复合年增长率（%） 10.92％

在当今充满活力的医疗保健和製药环境中，委外研发机构(CRO) 是致力于创新和高效将产品推向市场的公司的重要合作伙伴。近年来，在突破性科学发现、监管变化和技术快速进步的推动下，该行业经历了重大变革。这种转变将 CRO 的角色从单纯的服务提供者提升为策略合作者，旨在克服发展障碍和管理复杂的多学科计划。

数位资料管理和自动化实验室流程等先进方法的整合现在使 CRO 能够简化业务、缩短交付时间并提高整体研究品质。相关人员现在面临着包括成本压力、缓慢的病患招募和严格的监管要求等挑战。采用尖端技术和强大的分析能力将使公司在临床研究和开发中实现更高的效率。

在这种竞争格局中，CRO 的价值提案因其提供专业知识和敏捷营运模式的能力而凸显。这一介绍观点为深入探讨转型转变、细微细分以及精准的区域和公司分析如何重塑产业奠定了基础。随着市场动态的不断发展，决策者发现全面的洞察力对于指南策略性投资、优化资源配置和利用新的商业机会变得更加重要。

重新定义合约研究格局的变革

在过去十年中，一系列变革改变了研究外包格局，改变了服务的交付方式和相关人员的价值感知方式。现代 CRO 不再只是服务提供者；他们是深度参与临床试验设计和执行的策略合作伙伴，利用数位工具和进阶分析来推动更好的结果。这种对技术整合的新重视是当前转型的根本催化剂。

从历史上看，该行业的特点是采用传统的、孤立的研究服务方式。然而，随着先进的数位平台、资料管理系统和人工智慧的出现，自动化和即时资料分析正在共同推动进步。这些发展提高了效率，改善了法规遵循并缩短了时间表。公司正在采取积极主动的态度，同时应对可扩展性、成本优化和复杂的试验管理等挑战。

此外，不断变化的监管要求以及客户和患者不断提高的期望要求重新评估研究方案和调查方法。人们需要更细粒度的资料流和整合不同资讯来源的能力。这种变化不仅是技术性的，也是策略性的，因为产业领导者重新调整其业务框架和经营模式以保持竞争力。现代临床研究的协作性质，加上整合的供应链，意味着从发现到临床前到临床服务的所有要素都是相互关联的，从而推动每个阶段的创新。

推动市场动态的关键细分洞察

全面了解市场细分对于识别成长机会和策略定位起着关键作用。市场研究基于临床研究服务、咨询服务、资料管理服务、市场开发、化验服务和临床前服务等服务类型。早期开发进一步细分为专注于化学、製造和控制、发现研究和临床前服务的专业部门，而实验室服务也分为特定的子类别，如分析测试和生物分析测试。这种分层方法加深了对服务提供多样化的理解。

同时，基于测试类型的分析强调了体外和体内测试的重要性。评估这些研究模式可以为 CRO 范围内的方法偏好和性能优势提供重要的见解。此外，按治疗领域细分可以揭示面临的疾病和病症的市场，例如循环系统疾病、中枢神经系统疾病、皮肤病感染疾病、消化器官系统、传染病、肿瘤学、眼科学等。这些治疗领域推动了产业内的研究重点和资源分配。

此外，基于最终用户的市场区隔也正在获得显着发展动能。学术和研究机构、农业化学品和农药公司、生技公司、政府机构和製药公司各自都有独特的需求和期望。透过分析这些基本要素，相关人员能够根据每个群体的具体需求制定策略，从而提高参与度和更有效的市场渗透率。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 药物开发过程日益复杂
      • 医药研发投入快速增加
      • 研究活动中越来越多采用外包服务
    • 限制因素
      • 对临床试验过程中资料安全和病患隐私的担忧
    • 机会
      • 专注于先进细胞和基因治疗的新型临床试验设计和通讯协定
      • CRO实施的数位化与敏捷製造/研发技术
    • 任务
      • 临床研究中的患者招募和保留问题。
  • 市场区隔分析
    • 类型：专注于临床前服务中的新化合物发现
    • 最终用户：生技公司越来越多地使用 CRO 服务
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章受託研究机构服务市场按类型

  • 临床研究服务
  • 咨询服务
  • 资料管理服务
  • 早期开发服务
    • 化学、製造和控制
    • 探索研究
    • 临床前服务
  • 化验服务
    • 分析测试
    • 生物分析测试
  • 临床前服务

第七章受託研究机构服务市场按测试类型

  • 体外测试
  • 体内测试

第八章受託研究机构服务市场按治疗领域

  • 心血管疾病
  • 中枢神经系统疾病
  • 皮肤科
  • 消化系统疾病
  • 感染疾病
  • 肿瘤学
  • 眼科

第九章受託研究机构服务市场依最终用户划分

  • 学术研究所
  • 农业化学品和杀虫剂公司
  • 生技公司
  • 政府
  • 製药公司

10. 美洲受託研究机构服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

11. 亚太受託研究机构服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12. 欧洲、中东和非洲受託研究机构服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章 竞争格局

  • 2024 年市场占有率分析
  • FPNV 定位矩阵，2024 年
  • 竞争情境分析
  • 战略分析与建议

公司列表

  • Advanced Clinical LLC
  • Alcanza Clinical Research, LLC.
  • Almac Group LIMITED
  • CELERION, INC.
  • Charles River Laboratories International, Inc.
  • CLINTEC INTERNATIONAL PRIVATE LIMITED
  • dMedClinical Co. Ltd.
  • Envigo, Inc.
  • Ergomed Plc
  • Eurofins Scientific SE
  • ICON plc
  • IQVIA Private Limited
  • KCR SA
  • LabCorp Laboratory Corporation
  • Linical Co.,Ltd.
  • Medpace Holdings, Inc.
  • Novotech Clinical Research India Private Limited
  • Parexel International（MA）Corporation
  • PPD Inc. by Thermo Fisher Scientific Inc.
  • Premier Research Group Limited
  • PSI CRO AG
  • Quotient Sciences Limited
  • SGS SA
  • SIGNANT HEALTH LIMITED
  • Syneos Health Inc.
  • TFS International AB
  • Veristat, LLC
  • Worldwide Clinical Trials Holdings, Inc.
  • WuXi AppTec Co., Ltd.
Product Code: MRR-EF0BD2D82C3B

The Contract Research Organizations Services Market was valued at USD 77.42 billion in 2024 and is projected to grow to USD 85.72 billion in 2025, with a CAGR of 10.92%, reaching USD 144.20 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 77.42 billion
Estimated Year [2025] USD 85.72 billion
Forecast Year [2030] USD 144.20 billion
CAGR (%) 10.92%

In today's dynamic healthcare and pharmaceutical environment, contract research organizations (CROs) serve as pivotal partners for companies striving to innovate and bring products to market efficiently. The industry has seen substantial evolution over recent years, driven by groundbreaking scientific discoveries, regulatory changes, and a rapid pace of technological advancement. This transformation enhances the role of CROs from simple service providers to strategic collaborators intended to overcome developmental hurdles and manage complex, multidisciplinary projects.

The integration of advanced methodologies, including digital data management and automated laboratory processes, has allowed CROs to streamline operations, reduce turnaround times, and increase overall research quality. Stakeholders are now better positioned to face challenges such as cost pressures, patient recruitment delays, and stringent regulatory demands. With the incorporation of cutting-edge technologies and robust analytics, organizations are empowered to achieve higher efficiency levels in their clinical research and development endeavors.

Throughout this competitive landscape, the value proposition of CROs is underscored by their ability to offer specialized expertise coupled with agile operational models. This introductory outlook sets the stage for a deeper dive into how transformative shifts, nuanced segmentation, and precise regional and corporate analyses are reshaping the industry. As market dynamics continue to evolve, decision-makers find themselves more reliant on comprehensive insights to guide strategic investments, optimize resource allocation, and capitalize on emerging business opportunities.

Transformative Shifts Redefining the Contract Research Landscape

The contract research landscape has been shaped by a series of transformative shifts over the past decade, revolutionizing the way services are delivered and how stakeholders perceive value. Modern CROs are no longer just service executors; they are strategic partners deeply involved in the design and implementation of clinical trials, leveraging digital tools and sophisticated analytics to drive better outcomes. This newfound emphasis on technology integration is one of the fundamental catalysts behind the current transformation.

Historically, the industry was characterized by traditional, siloed approaches to research services. However, with the advent of advanced digital platforms, data management systems, and artificial intelligence, there is now a concerted push towards automation and real-time data analysis. These developments have given rise to enhanced efficiencies, improved regulatory compliance, and accelerated timelines. Companies are increasingly adopting a proactive stance, concurrently addressing the challenges of scalability, cost optimization, and complex trial management.

Furthermore, evolving regulatory mandates and heightened expectations from both clients and patients have necessitated a re-evaluation of research protocols and testing methodologies. Emphasis has shifted towards patient-centric models and precision medicine, demanding more detailed data streams and our ability to integrate diverse sources of information. The change is not merely technical but also strategic, as industry leaders realign their operational frameworks and business models to remain competitive. The collaborative nature of modern clinical research, coupled with an integrated supply chain, ensures that every component from discovery through to preclinical and clinical services is interconnected, fostering innovation at every step.

Key Segmentation Insights Driving Market Dynamics

A comprehensive understanding of market segmentation plays a critical role in identifying key opportunities for growth and strategic positioning. The market is studied based on service types that encompass clinical research services, consulting services, data management services, early phase development, laboratory services, and preclinical services. Within early phase development, further breakdown occurs through specialized divisions focusing on chemistry, manufacturing and control, discovery studies, and preclinical services, while laboratory services also branch into specific subcategories such as analytical testing alongside bioanalytical testing. This layered approach provides depth in understanding the diversification of service offerings.

In parallel, analysis based on testing types highlights the importance of both in-vitro and in-vivo testing. Evaluating these testing modalities yields critical insights into methodological preferences and performance advantages across the spectrum of CRO activities. Moreover, segmentation by therapeutic areas illuminates markets challenged by diseases and conditions such as cardiovascular diseases, central nervous system disorders, dermatology, gastrointestinal ailments, infectious diseases, oncology, and ophthalmology. These therapeutic focuses drive research priorities and resource allocation within the industry.

Additionally, the market's segmentation based on end-users is gaining crucial momentum. Academic and research institutes, agrochemical and pesticide companies, biotechnology companies, government organizations, and pharmaceutical companies each bring unique demands and expectations. Analyzing these components enables stakeholders to tailor strategies that resonate with the specific requirements of each group, thus fostering improved engagement and more effective market penetration.

Based on Type, market is studied across Clinical Research Services, Consulting Services, Data Management Services, Early Phase Development Services, Laboratory Services, and Preclinical Services. The Early Phase Development Services is further studied across Chemistry, Manufacturing & Control, Discovery Studies, and Preclinical Services. The Laboratory Services is further studied across Analytical Testing and Bioanalytical Testing.

Based on Testing Type, market is studied across In-Vitro Testing and In-Vivo Testing.

Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Central Nervous System Disorders, Dermatology, Gastrointestinal Diseases, Infectious Diseases, Oncology, and Ophthalmology.

Based on End-User, market is studied across Academic & Research Institutes, Agrochemical & Pesticide Companies, Biotechnology Companies, Government Organizations, and Pharmaceutical Companies.

Critical Regional Insights Shaping Global Opportunities

A nuanced regional analysis underlines the certainty that geographic diversity influences market opportunities and competitive landscapes. In the Americas, the mature market displays robust investment in research infrastructure combined with evolving regulatory reforms that promote innovation and collaboration. Meanwhile, the combined region of Europe, Middle East & Africa offers a mix of highly developed research hubs alongside emerging growth markets where regulatory harmonization is streamlining processes and enabling access to international clinical trials. Most notably, the Asia-Pacific region has been rapidly expanding owing to ongoing governmental initiatives, increasing investment in healthcare infrastructure, and rising demand for innovative therapies.

This interplay between established economies and emerging markets is critical for stakeholders seeking to identify priority areas for growth. Embracing regional diversity not only offers potential for improved access to capital, but also incentivizes the adoption of cutting-edge technologies and best practices that could be replicated across other markets. As a result, understanding these regional trends and developing localized strategies is fundamental to maintaining competitive advantage in a globally interconnected environment.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

In-Depth Company Insights Unveiling Industry Leaders

Evaluating key players in the market furnishes a vivid picture of competitive dynamics and operational excellence within the industry. The landscape includes companies such as Advanced Clinical LLC, Alcanza Clinical Research, LLC., and Almac Group LIMITED, each recognized for their robust service portfolios and innovative approaches. Equally important are organizations like CELERION, INC. and Charles River Laboratories International, Inc., which have consistently set benchmarks in reliability and quality. Continued success is also seen with firms such as CLINTEC INTERNATIONAL PRIVATE LIMITED, dMedClinical Co. Ltd., and Envigo, Inc. - all demonstrating agility in adapting to evolving market demands.

Other notable contributors include Ergomed Plc, Eurofins Scientific SE, ICON plc, and IQVIA Private Limited. Their commitment to integrating advanced technological solutions with traditional research paradigms has paved the way for streamlined clinical trial processes. Often, companies such as KCR S.A., LabCorp Laboratory Corporation, Linical Co.,Ltd., Medpace Holdings, Inc., and Novotech Clinical Research India Private Limited have gained reputations for timely project delivery and comprehensive end-to-end solutions. Market leaders like Parexel International (MA) Corporation, PPD Inc. by Thermo Fisher Scientific Inc., Premier Research Group Limited, PSI CRO AG, Quotient Sciences Limited, SGS SA, SIGNANT HEALTH LIMITED, Syneos Health Inc., TFS International AB, Veristat, LLC, Worldwide Clinical Trials Holdings, Inc., and WuXi AppTec Co., Ltd. have also contributed significantly by fostering innovation and best practices across varied research disciplines.

These companies not only reflect the competitive intensity of the market but also serve as benchmark drivers whose strategic decisions and operational efficiencies impact the broader industry landscape. Their ongoing initiatives highlight the pressing need for agility, thought leadership, and robust research capabilities in today's fast-evolving clinical research environment.

The report delves into recent significant developments in the Contract Research Organizations Services Market, highlighting leading vendors and their innovative profiles. These include Advanced Clinical LLC, Alcanza Clinical Research, LLC., Almac Group LIMITED, CELERION, INC., Charles River Laboratories International, Inc., CLINTEC INTERNATIONAL PRIVATE LIMITED, dMedClinical Co. Ltd., Envigo, Inc., Ergomed Plc, Eurofins Scientific SE, ICON plc, IQVIA Private Limited, KCR S.A., LabCorp Laboratory Corporation, Linical Co.,Ltd., Medpace Holdings, Inc., Novotech Clinical Research India Private Limited, Parexel International (MA) Corporation, PPD Inc. by Thermo Fisher Scientific Inc., Premier Research Group Limited, PSI CRO AG, Quotient Sciences Limited, SGS SA, SIGNANT HEALTH LIMITED, Syneos Health Inc., TFS International AB, Veristat, LLC, Worldwide Clinical Trials Holdings, Inc., and WuXi AppTec Co., Ltd.. Actionable Recommendations for Forward-Thinking Industry Leaders

To thrive amidst the rapidly evolving research landscape, industry leaders are advised to adopt a multi-faceted strategy built on innovation, efficiency, and collaboration. Leaders should focus on investing in advanced digital tools that streamline data acquisition and analysis, ultimately reducing the turnaround times for essential clinical projects. Diversification in service portfolios, with a keen understanding of both traditional and emerging therapeutic areas, is essential to meet the rising demands of diverse end-user segments. Continuing to integrate state-of-the-art automation and technological solutions will ensure that operations remain scalable and efficient in a competitive market.

It is imperative to nurture strategic partnerships that leverage global expertise and local market knowledge, thereby mitigating risks associated with regional regulatory complexities. Additionally, refining methodologies to incorporate both in-vitro and in-vivo testing is crucial for fine-tuning research outcomes. Leaders should emphasize not only meeting current market standards but consistently evolving to set new benchmarks for quality and innovation. Investing in training and upskilling teams and integrating comprehensive risk management strategies will further contribute to sustainable growth and improved operational efficiency.

Adopting a proactive market strategy that anticipates shifts in therapeutic priorities and patient-centric research trends will provide a strategic edge. In doing so, industry leaders stand well-prepared to capitalize on emerging opportunities while simultaneously mitigating potential market disruptions.

Conclusion: Navigating a Complex and Dynamic Market Environment

In conclusion, the contract research industry is experiencing an era of profound transformation driven by rapid technological advancement, evolving regulatory norms, and diversification in service and customer needs. The strategic segmentation based on research services, testing types, therapeutic areas, and end-user requirements highlights a complex yet opportunity-rich environment. Regional insights underscore the importance of understanding local market dynamics, while key company evaluations reveal the capabilities and strategic prowess that drive industry standards. As stakeholders continue to grapple with a fast-evolving ecosystem, there is a compelling argument for proactive adaptation, strategic investments, and collaborative synergies to secure sustained success in the years ahead.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing complexity of drug development processes
      • 5.1.1.2. Surge in investments in pharmaceutical research and development
      • 5.1.1.3. Rise in adoption of outsourced services for research activities
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns over data security and patient privacy in clinical trial processes
    • 5.1.3. Opportunities
      • 5.1.3.1. Emphasis on novel clinical trial designs and protocols for more advanced cell and gene therapy
      • 5.1.3.2. Adoption of digitized and agile manufacturing and research development techniques by CROs
    • 5.1.4. Challenges
      • 5.1.4.1. Issues of patient recruitment and retention for clinical research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing emphasis on discovery studies to identify new compounds in preclinical services
    • 5.2.2. End User: Expanding utilization of CRO services by biotechnology firms
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Contract Research Organizations Services Market, by Type

  • 6.1. Introduction
  • 6.2. Clinical Research Services
  • 6.3. Consulting Services
  • 6.4. Data Management Services
  • 6.5. Early Phase Development Services
    • 6.5.1. Chemistry, Manufacturing & Control
    • 6.5.2. Discovery Studies
    • 6.5.3. Preclinical Services
  • 6.6. Laboratory Services
    • 6.6.1. Analytical Testing
    • 6.6.2. Bioanalytical Testing
  • 6.7. Preclinical Services

7. Contract Research Organizations Services Market, by Testing Type

  • 7.1. Introduction
  • 7.2. In-Vitro Testing
  • 7.3. In-Vivo Testing

8. Contract Research Organizations Services Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiovascular Diseases
  • 8.3. Central Nervous System Disorders
  • 8.4. Dermatology
  • 8.5. Gastrointestinal Diseases
  • 8.6. Infectious Diseases
  • 8.7. Oncology
  • 8.8. Ophthalmology

9. Contract Research Organizations Services Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Agrochemical & Pesticide Companies
  • 9.4. Biotechnology Companies
  • 9.5. Government Organizations
  • 9.6. Pharmaceutical Companies

10. Americas Contract Research Organizations Services Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Contract Research Organizations Services Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Contract Research Organizations Services Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Strategic partnership between Novotech and Biostar enhances clinical research innovations
    • 13.3.2. Novotech enhances early-phase biotech trials expertise with new strategic delivery unit
    • 13.3.3. Parexel and Palantir partner to enhance clinical trials with AI-driven innovations
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Clinical LLC
  • 2. Alcanza Clinical Research, LLC.
  • 3. Almac Group LIMITED
  • 4. CELERION, INC.
  • 5. Charles River Laboratories International, Inc.
  • 6. CLINTEC INTERNATIONAL PRIVATE LIMITED
  • 7. dMedClinical Co. Ltd.
  • 8. Envigo, Inc.
  • 9. Ergomed Plc
  • 10. Eurofins Scientific SE
  • 11. ICON plc
  • 12. IQVIA Private Limited
  • 13. KCR S.A.
  • 14. LabCorp Laboratory Corporation
  • 15. Linical Co.,Ltd.
  • 16. Medpace Holdings, Inc.
  • 17. Novotech Clinical Research India Private Limited
  • 18. Parexel International (MA) Corporation
  • 19. PPD Inc. by Thermo Fisher Scientific Inc.
  • 20. Premier Research Group Limited
  • 21. PSI CRO AG
  • 22. Quotient Sciences Limited
  • 23. SGS SA
  • 24. SIGNANT HEALTH LIMITED
  • 25. Syneos Health Inc.
  • 26. TFS International AB
  • 27. Veristat, LLC
  • 28. Worldwide Clinical Trials Holdings, Inc.
  • 29. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET MULTI-CURRENCY
  • FIGURE 2. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET RESEARCH PROCESS
  • FIGURE 4. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY CHEMISTRY, MANUFACTURING & CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY DISCOVERY STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY IN-VITRO TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY IN-VIVO TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY AGROCHEMICAL & PESTICIDE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 263. SWEDEN CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 275. TURKEY CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES CONTRACT RESEARCH ORGANIZATIONS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES CONTRACT RE